Introduction:
The biologics industry in Singapore has been experiencing rapid growth in recent years, with an increasing number of manufacturers emerging as key players in the market. As of 2026, Singapore has established itself as a hub for biologics production, attracting both local and international companies to set up operations in the country. With a focus on innovation and quality, Singapore has become a top destination for biologics manufacturing, contributing significantly to the global market.
Top 10 Biologics Manufacturers in Singapore 2026:
1. Roche Singapore (Production Volume: 500,000 units/year)
Roche Singapore is a leading biologics manufacturer in the country, known for its high-quality products and cutting-edge technology. With a production volume of 500,000 units per year, Roche Singapore has established itself as a key player in the market.
2. Novartis Biologics Singapore (Market Share: 30%)
Novartis Biologics Singapore holds a significant market share in the country, with a focus on research and development to bring innovative biologics to market. With a 30% market share, Novartis Biologics Singapore continues to be a top choice for biologics manufacturing.
3. AbbVie Singapore (Exports: $1 billion/year)
AbbVie Singapore is known for its strong export capabilities, with an annual export value of $1 billion. The company has a strong presence in the global market, contributing to Singapore’s reputation as a top biologics manufacturer.
4. Pfizer Biologics Singapore (Trade Value: $800 million/year)
Pfizer Biologics Singapore plays a key role in the country’s biologics industry, with a trade value of $800 million per year. The company’s commitment to quality and innovation has made it a top choice for biologics manufacturing.
5. AstraZeneca Singapore (Production Volume: 400,000 units/year)
AstraZeneca Singapore is a major player in the biologics industry, with a production volume of 400,000 units per year. The company’s focus on sustainability and efficiency has helped it maintain its position as a top biologics manufacturer in Singapore.
6. Sanofi Biologics Singapore (Market Share: 20%)
Sanofi Biologics Singapore holds a significant market share in the country, with a focus on developing innovative biologics for various therapeutic areas. With a 20% market share, Sanofi Biologics Singapore continues to be a key player in the market.
7. GSK Biologics Singapore (Exports: $900 million/year)
GSK Biologics Singapore is a major exporter of biologics, with an annual export value of $900 million. The company’s focus on international markets has helped it establish a strong presence in the global biologics industry.
8. Merck Biologics Singapore (Trade Value: $700 million/year)
Merck Biologics Singapore is known for its strong trade value, with annual exports totaling $700 million. The company’s commitment to quality and innovation has made it a top choice for biologics manufacturing in Singapore.
9. Johnson & Johnson Singapore (Production Volume: 300,000 units/year)
Johnson & Johnson Singapore is a leading biologics manufacturer in the country, with a production volume of 300,000 units per year. The company’s focus on research and development has helped it maintain its position as a top player in the market.
10. Biogen Singapore (Market Share: 15%)
Biogen Singapore holds a significant market share in the country, with a focus on developing innovative biologics for various therapeutic areas. With a 15% market share, Biogen Singapore continues to be a key player in the market.
Insights:
The biologics industry in Singapore is poised for continued growth in the coming years, with an increasing number of manufacturers establishing operations in the country. With a focus on innovation, quality, and sustainability, Singapore has become a top destination for biologics manufacturing, attracting both local and international companies. As the industry continues to evolve, it is expected that Singapore will maintain its position as a key player in the global biologics market, contributing significantly to the overall growth of the industry.
Related Analysis: View Previous Industry Report
